NL970037I1 - Werkwijze voor hormonale behandeling van peri-menopausale, menopausale en post-menopausale stoornissen en een meervoudig preparatenpakket daarvoor. - Google Patents

Werkwijze voor hormonale behandeling van peri-menopausale, menopausale en post-menopausale stoornissen en een meervoudig preparatenpakket daarvoor.

Info

Publication number
NL970037I1
NL970037I1 NL970037C NL970037C NL970037I1 NL 970037 I1 NL970037 I1 NL 970037I1 NL 970037 C NL970037 C NL 970037C NL 970037 C NL970037 C NL 970037C NL 970037 I1 NL970037 I1 NL 970037I1
Authority
NL
Netherlands
Prior art keywords
menopausal
peri
post
disorders
hormonal treatment
Prior art date
Application number
NL970037C
Other languages
English (en)
Other versions
NL970037I2 (nl
Original Assignee
Pre Jay Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27060286&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL970037(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pre Jay Holdings Ltd filed Critical Pre Jay Holdings Ltd
Publication of NL970037I1 publication Critical patent/NL970037I1/nl
Publication of NL970037I2 publication Critical patent/NL970037I2/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
NL970037C 1983-08-05 1997-10-22 Werkwijze voor hormonale behandeling van peri-menopausale, menopausale en post-menopausale stoornissen en een meervoudige preparatenpakket daarvoor. NL970037I2 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52083483A 1983-08-05 1983-08-05
US06/635,236 US4826831A (en) 1983-08-05 1984-07-27 Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens

Publications (2)

Publication Number Publication Date
NL970037I1 true NL970037I1 (nl) 1998-02-02
NL970037I2 NL970037I2 (nl) 2004-04-01

Family

ID=27060286

Family Applications (5)

Application Number Title Priority Date Filing Date
NL970026C NL970026I1 (nl) 1983-08-05 1997-07-22 Werkwijze voor hormonale behandeling van peri-menopausale, menopausale en post-menopausale stoornissen en een meervoudig preparatenpakket daarvoor.
NL970037C NL970037I2 (nl) 1983-08-05 1997-10-22 Werkwijze voor hormonale behandeling van peri-menopausale, menopausale en post-menopausale stoornissen en een meervoudige preparatenpakket daarvoor.
NL980038C NL980038I2 (nl) 1983-08-05 1998-11-20 Werkwijze voor hormonale behandeling van peri-menopausale, meno-pausale en post-menopausale stoornissen en een meervoudig preparatenpakket daarvoor.
NL300022C NL300022I2 (nl) 1983-08-05 2000-10-23 Werkwijze voor hormonale behandeling van peri-menopausale, menopausale en post-menopausale stoornissen en een meervoudige preparatenpakket daarvoor.
NL300033C NL300033I2 (nl) 1983-08-05 2001-01-04 Werkwijze voor hormonale behandeling van peri-menopausale, meno-pausale en post-menopausale stoornissen en een meervoudige preparatenpakket daarvoor.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NL970026C NL970026I1 (nl) 1983-08-05 1997-07-22 Werkwijze voor hormonale behandeling van peri-menopausale, menopausale en post-menopausale stoornissen en een meervoudig preparatenpakket daarvoor.

Family Applications After (3)

Application Number Title Priority Date Filing Date
NL980038C NL980038I2 (nl) 1983-08-05 1998-11-20 Werkwijze voor hormonale behandeling van peri-menopausale, meno-pausale en post-menopausale stoornissen en een meervoudig preparatenpakket daarvoor.
NL300022C NL300022I2 (nl) 1983-08-05 2000-10-23 Werkwijze voor hormonale behandeling van peri-menopausale, menopausale en post-menopausale stoornissen en een meervoudige preparatenpakket daarvoor.
NL300033C NL300033I2 (nl) 1983-08-05 2001-01-04 Werkwijze voor hormonale behandeling van peri-menopausale, meno-pausale en post-menopausale stoornissen en een meervoudige preparatenpakket daarvoor.

Country Status (12)

Country Link
US (2) US4826831A (nl)
EP (1) EP0136011B2 (nl)
AT (1) ATE147987T1 (nl)
CA (1) CA1240927A (nl)
DE (5) DE19775086I2 (nl)
DK (2) DK165390C (nl)
IL (1) IL72556A (nl)
LU (5) LU90107I2 (nl)
MX (1) MX9203720A (nl)
NL (5) NL970026I1 (nl)
NZ (1) NZ209066A (nl)
PH (1) PH24052A (nl)

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4961931A (en) * 1982-07-29 1990-10-09 Alza Corporation Method for the management of hyperplasia
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
IE61236B1 (en) * 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
CH674618A5 (nl) * 1987-04-02 1990-06-29 Ciba Geigy Ag
ES2024010B3 (es) * 1987-07-06 1992-02-16 Akzo Nv Unidad de dosis farmaceutica.
US4900734A (en) * 1987-08-27 1990-02-13 Maxson Wayne S Novel pharmaceutical composition containing estradiol and progesterone for oral administration
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
EP0322020A1 (en) * 1987-12-22 1989-06-28 Akzo N.V. Pharmaceutical dosage unit for treating climacteric complaints and osteoporosis
HUT52382A (en) * 1988-03-14 1990-07-28 Sandoz Ag Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
GB8813353D0 (en) * 1988-06-06 1988-07-13 Ici Plc Therapeutic product
ES2077675T3 (es) * 1989-03-10 1995-12-01 Endorecherche Inc Terapia combinada para el tratamiento de enfermedades sensibles a los estrogenos.
US5043331A (en) * 1989-06-15 1991-08-27 Orion-Yhtyma Oy Treatment of postmenopausal disorders
ZA924811B (en) * 1991-06-28 1993-12-29 Endorecherche Inc Controlled release systems and low dose androgens
HU222501B1 (hu) * 1991-06-28 2003-07-28 Endorecherche Inc. MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
IL107343A (en) * 1992-11-02 2003-10-31 Wyeth Corp PHARMACEUTICAL COMPOSITION FOR LOWERING BLOOD LIPID LEVEL, COMPRISING, 17alpha-DIHYDROEQUILENIN
ZA94715B (en) * 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints
US5710144A (en) * 1993-02-08 1998-01-20 Akzo Nobel N.V. C-11 substituted steroids for treating menopausal complaints
US6037339A (en) 1993-02-08 2000-03-14 Akzo Nobel N.V. C-11 substituted steroids for treating menopausal complaints
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
DE19510861A1 (de) * 1995-03-16 1996-09-19 Schering Ag Einmonatsspritze als Depot-Kontrazeptivum und für die Hormonersatztherapie für peri- und praemenopausale Frauen
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
WO1997004752A1 (en) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
FR2737411B1 (fr) * 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
US5654011A (en) * 1996-07-30 1997-08-05 Energetics, Inc. Dietary supplements
US6040333A (en) * 1996-07-30 2000-03-21 Energetics, Inc. Dietary supplements
US5807586A (en) * 1996-07-30 1998-09-15 Energetics, Inc. Method of dietary supplementation
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
AU4957999A (en) * 1998-07-17 2000-02-07 Pharmacia & Upjohn Company Subcutaneous medroxyprogesterone acetate for contraception
US6165504A (en) * 1998-09-23 2000-12-26 Barr Laboratories, Inc. Methods for treating hot flashes and improving the quality of life of castrated prostatic cancer patients
AU1197100A (en) * 1998-10-09 2000-05-01 Pharmacia & Upjohn Company Subcutaneous medroxyprogesterone acetate for treatment of menopause and endometriosis
US6613758B1 (en) 1999-04-02 2003-09-02 Barr Laboratories, Inc. Method for treating osteoporosis in castrated prostatic cancer patients
US6703367B1 (en) 1999-04-27 2004-03-09 Praecis Pharmaceuticals Inc. Methods for treating hot flashes and gynaecomastia
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
WO2001030356A1 (fr) * 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
US7025979B2 (en) 2000-02-15 2006-04-11 Schering Ag Male contraceptive formulation comprising norethisterone
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US20010034340A1 (en) * 2000-03-20 2001-10-25 American Home Products Corporation Hormone replacement therapy
US20020151530A1 (en) * 2000-12-22 2002-10-17 Leonard Thomas W. Method of treating hormonal deficiencies in women undergoing estrogen replacement therapy
DE10100911A1 (de) * 2001-01-11 2002-08-01 Schering Ag Verfahren zur Hormonersatztherapie und dessen Darreichungsform
US20060142257A1 (en) * 2001-01-19 2006-06-29 Eberhard Nieschlag Male contraceptive formulation comprising norethisterone
WO2002074292A2 (en) * 2001-03-16 2002-09-26 Wyeth Hormone replacement therapy
CA2441252A1 (en) * 2001-03-16 2002-10-10 Wyeth Estrogen replacement therapy
FR2823976A1 (fr) * 2001-04-25 2002-10-31 Theramex Nouvelle composition hormonale et son utilisation
US20130203722A1 (en) 2006-09-26 2013-08-08 Rhonda R. Voskuhl Estriol therapy for autoimmune and neurodegenerative disease and disorders
CA2446849A1 (en) 2001-05-16 2002-11-21 Endeavor Pharmaceuticals Treatment of conditions relating to hormone deficiencies by administration of progestins
EP1406634A1 (en) * 2001-07-13 2004-04-14 Schering Aktiengesellschaft Combination of drospirenone and an estrogen sulphamate for hrt
WO2003018026A1 (en) * 2001-08-31 2003-03-06 Pantarhei Bioscience B.V. Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
EP1453521B1 (en) 2001-12-05 2013-09-04 Teva Women's Health, Inc. Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
US20030216366A1 (en) * 2002-04-03 2003-11-20 Leonard Thomas W. Step-down estrogen therapy
US20030191096A1 (en) * 2002-04-03 2003-10-09 Leonard Thomas W. Method of hormonal therapy
TW200306851A (en) * 2002-04-29 2003-12-01 Wyeth Corp Hormone replacement therapy
TW200404551A (en) * 2002-05-17 2004-04-01 Wyeth Corp Hormone replacement therapy
TW200400040A (en) * 2002-05-17 2004-01-01 Wyeth Corp Hormone replacement therapy
ES2277139T3 (es) * 2002-08-28 2007-07-01 Robert Casper Regimen de reposicion de estrogenos.
EP1462106A1 (en) * 2003-03-28 2004-09-29 Pantarhei Bioscience B.V. Pharmaceutical compositions and kits comprising 17-beta-estradiol and a progesteron for the treatment of gynecological disorders
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
CA2521471A1 (en) * 2003-04-11 2004-10-28 Barr Laboratories, Inc. Methods of administering estrogens and progestins
US7772219B2 (en) * 2003-05-02 2010-08-10 Teva Women's Health, Inc. Methods of hormonal treatment utilizing extended cycle contraceptive regimens
AU2004257772B2 (en) * 2003-07-16 2009-12-17 Teva Women's Health, Inc. Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
ES2933479T3 (es) * 2003-09-29 2023-02-09 Novo Nordisk Healthcare Ag Estabilidad mejorada de formulaciones de progestágenos
DK1670440T3 (da) 2003-09-29 2014-07-07 Novo Nordisk As HRT formuleringer
AU2005249401A1 (en) * 2004-05-26 2005-12-15 Wyeth Compositions and methods for treatment of premenstrual dysphoric disorder
DE102004026669A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Verwendung einer Kombination aus Ethinylestradiol und Chlormadinonacetat zur Herstellung eines Arzneimittels
DE102004026679A1 (de) 2004-05-28 2005-12-15 Grünenthal GmbH Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
US20060040904A1 (en) * 2004-08-17 2006-02-23 Ahmed Salah U Vaginal cream compositions, kits thereof and methods of using thereof
US20070111975A1 (en) * 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
EP1853272A1 (en) * 2005-02-03 2007-11-14 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
EP1971325A2 (en) * 2005-12-27 2008-09-24 Duramed Pharmaceuticals, Inc. Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
US20080242650A1 (en) * 2007-03-26 2008-10-02 Jean-Louis Thomas Oral contraceptive regimen
EP2164498A4 (en) 2007-06-04 2010-09-08 Univ California PREGNANCY HORMONE ASSOCIATION FOR THE TREATMENT OF AUTOIMMUNE DISEASES
BR112012026115B1 (pt) 2010-04-15 2019-12-24 Bayer Ip Gmbh forma de dosagem oral sólida, seu uso, e unidade de acondicionamento
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
PT2782584T (pt) 2011-11-23 2021-09-02 Therapeuticsmd Inc Preparações e terapias de substituição para hormonoterapias naturais combinadas
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10369158B2 (en) 2014-04-28 2019-08-06 The Regents Of The University Of California Pharmaceutical packaging for estriol therapy
US10799512B2 (en) 2014-04-28 2020-10-13 The Regents Of The University Of California Estrogen combination for treatment of multiple sclerosis
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
WO2016036719A1 (en) 2014-09-02 2016-03-10 The Regents Of The University Of California Estrogen therapy for brain gray matter atrophy and associated disability
US9962395B2 (en) 2014-09-29 2018-05-08 The Regents Of The University Of California Compositions and methods for maintaining cognitive function
US10406169B2 (en) 2015-03-30 2019-09-10 The Regents Of The University Of California Methods of monitoring estriol therapy
PE20231714A1 (es) 2015-06-18 2023-10-23 Estetra Sprl Unidad de dosificacion orodispersable que contiene un componente estetrol
UA123098C2 (uk) 2015-06-18 2021-02-17 Естетра Спрл Диспергована у порожнині рота одиниця дозування, що містить естетрольний компонент
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
CA3020153A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639600A (en) * 1969-08-28 1972-02-01 Upjohn Co Process of establishing cyclicity in a human female
US3733407A (en) * 1971-08-25 1973-05-15 Syntex Corp Menopause treatment
US3836651A (en) * 1972-02-22 1974-09-17 Biolog Concepts Inc Novel oral contraceptive combination
DE2365103C3 (de) * 1973-12-21 1980-08-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen V erwendung von Hormonen zur Kontrazeption
US4018919A (en) * 1975-07-16 1977-04-19 Eli Lilly And Company Sequential contraceptive method using two types of progestational agents
DE2645307A1 (de) * 1976-10-05 1978-04-06 Schering Ag Neue mittel und neue methoden zur behandlung klimakterischer ausfallerscheinungen
GB1578340A (en) * 1977-11-15 1980-11-05 Normalair Garrett Ltd Mechanical hands eg for diving apparatus
US4425339A (en) * 1981-04-09 1984-01-10 Syntex (U.S.A.) Inc. Treatment of menopausal symptoms

Also Published As

Publication number Publication date
DK200400365A (da) 2004-03-04
ATE147987T1 (de) 1997-02-15
NL300033I1 (nl) 2001-03-01
DK377084D0 (da) 1984-08-03
DK165390C (da) 2004-04-26
NL300022I2 (nl) 2004-04-01
DE19775086I2 (de) 2001-08-23
DE10199010I2 (de) 2010-01-28
USRE36247E (en) 1999-07-06
DK175317B1 (da) 2004-08-16
DE10199001I2 (de) 2010-07-08
US4826831A (en) 1989-05-02
CA1240927A (en) 1988-08-23
EP0136011A3 (en) 1986-07-16
LU90107I2 (fr) 1997-12-17
EP0136011B1 (en) 1997-01-22
DE10199010I1 (de) 2002-05-08
NZ209066A (en) 1988-01-08
DE3486442D1 (de) 1997-03-06
DK377084A (da) 1985-02-06
DE10075037I2 (de) 2010-01-28
IL72556A (en) 1989-05-15
DE3486442T2 (de) 1997-06-05
PH24052A (en) 1990-03-05
EP0136011B2 (en) 2004-06-09
DE10199001I1 (de) 2002-03-14
NL300022I1 (nl) 2001-01-02
LU90697I2 (fr) 2001-02-13
LU91096I2 (fr) 2004-11-30
IL72556A0 (en) 1984-11-30
EP0136011A2 (en) 1985-04-03
DE3486442T3 (de) 2005-05-12
LU90343I2 (fr) 1999-03-29
MX9203720A (es) 1992-07-31
LU90696I2 (fr) 2001-02-13
NL980038I2 (nl) 2005-06-01
NL970037I2 (nl) 2004-04-01
NL300033I2 (nl) 2004-04-01
DK165390B (da) 1992-11-23
DE10075037I1 (de) 2001-03-01
NL970026I1 (nl) 1997-10-01
NL980038I1 (nl) 1999-02-01

Similar Documents

Publication Publication Date Title
NL970026I1 (nl) Werkwijze voor hormonale behandeling van peri-menopausale, menopausale en post-menopausale stoornissen en een meervoudig preparatenpakket daarvoor.
NL7601211A (nl) Werkwijze voor het winnen van warmte uit een gasprodukt en daartoe geschikte inrichting.
JPS5239258A (en) Apparatus for feeding sheet-like matters
NL7709982A (nl) Werkwijze voor het winnen van reagentia en produkten uit een afvalwaterstroom.
NL7503721A (nl) Werkwijze voor het afscheiden van een in hoofd- zaak uit waterstof bestaand recirculaatgas van de effluent afkomstig van een werkwijze voor het behandelen van koolwaterstoffen bij aanwe- zigheid van waterstof.
JPS51130681A (en) A process for purification of malodorous gas and its apparatus
JPS5229077A (en) Device for separating steel materials
JPS51125372A (en) Aprocess for preparing pregnane steroid-17-ester-21-halides
TAKEMURA et al. Calcium signaling: the role of inositol phosphates and the mechanisms of Ca~(2+) entry
JPS5225291A (en) Fixing or tightening fittings for wire, etc.
JPS5322241A (en) Branching and joining structure in overhead cableway s ystem
JPS5361862A (en) Method and apparatus for separating and transferring plate likearticles
JPS5264710A (en) Apparatus for pulling up vehicle in gravity acceleration transporting system
JPS521807A (en) Noise reducing apparatus of railway vehicle
ES8707054A1 (es) Un aparato y un metodo para uso en dispositivos de sincronizacion
FR2537145B1 (fr) Procede pour separer la 4-androstene-3,17-dione et la 1,4-androstadiene-3, 17-dione
JPS5337099A (en) Accepting apparatus for registered mail or the like
JPS51131792A (en) Device for arraying and padding articles
JPS51137899A (en) Transportation method of gas bushing
JPS526155A (en) Heat resisting anti-heat p ipe cover
JPS51122438A (en) Method for starting and stopping film feed in projector